Published On August 14th, 2024, the SiCORE-M Team and SiCORE-PM&SP conducted a formal teleconference with the Scientific Advisory Board (SAB) to discuss the ongoing research’s progress and future direction. The esteemed SAB member in attendance was Prof. Andrew Futreal, Professor of Genomic Medicine at the University of Texas, MD Anderson Cancer Center, Houston, US.
The teleconference commenced with a warm welcome from Assist. Prof. Woraphat Ratta-apha, Head of the Center of Research Excellence (SiCORE). The meeting featured a comprehensive presentation by Asst. Prof. Somponnat Sampattavanich, Director of SiCORE-PM&SP, alongside Assoc. Prof. Siwanon Jirawatnotai and Assist. Prof. Chalermchai Mitrpant. The presentation highlighted strategic approaches to cancer research and commercialization in Asia, emphasizing the importance of collaboration and internationalization. Updates on research activities were shared, including developing organoids and PDX models with a specific focus on KRAS mutant subtypes. The discussion also addressed the challenges and opportunities in cancer research, such as the complexities of the granting system in Thailand and the need for mixed organoid cultures. The potential of lipidomics in cancer treatment and the optimization of epigenetic therapy for sarcoma were also explored.
This productive teleconference underscored our unwavering commitment to advancing cancer research, inspiring us to continue our collaborative efforts to achieve significant breakthroughs.
